Amdocs Stock Performance
| DOX Stock | USD 81.94 0.87 1.07% |
The firm shows a Beta (market volatility) of 0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Amdocs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amdocs is expected to be smaller as well. At this point, Amdocs has a negative expected return of -0.0387%. Please make sure to confirm Amdocs' treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Amdocs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Amdocs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Amdocs is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 1.07 | Five Day Return (0.93) | Year To Date Return 2.22 | Ten Year Return 48.09 | All Time Return 485.29 |
Forward Dividend Yield 0.0257 | Payout Ratio | Forward Dividend Rate 2.11 | Dividend Date 2026-01-30 | Ex Dividend Date 2025-12-31 |
1 | Amdocs Q4 2025 Earnings Call Transcript | 11/11/2025 |
2 | Understanding Amdocs Reliance on International Revenue | 11/17/2025 |
3 | Quantbot Technologies LP Invests 984,000 in Amdocs Limited DOX | 12/09/2025 |
4 | 1 of Wall Streets Favorite Stock for Long-Term Investors and 2 We Turn Down | 12/17/2025 |
5 | Why Is Wix.com Up 4.8 percent Since Last Earnings Report | 12/19/2025 |
6 | Price Over Earnings Overview Amdocs | 12/22/2025 |
7 | Amdocs Ltd. A Dependable Dividend Stock Built on Operational Quality - Chartmill | 01/09/2026 |
8 | Is Amdocs Limited Trading At A 36 percent Discount | 01/14/2026 |
9 | 1 Safe-and-Steady Stock to Research Further and 2 That Underwhelm - The Globe and Mail | 01/28/2026 |
| Amdocs dividend paid on 30th of January 2026 | 01/30/2026 |
| Begin Period Cash Flow | 346.1 M | |
| Total Cashflows From Investing Activities | -2.1 M |
Amdocs Relative Risk vs. Return Landscape
If you would invest 8,358 in Amdocs on November 3, 2025 and sell it today you would lose (251.00) from holding Amdocs or give up 3.0% of portfolio value over 90 days. Amdocs is generating negative expected returns assuming volatility of 1.4391% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Amdocs, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Amdocs Target Price Odds to finish over Current Price
The tendency of Amdocs Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 81.94 | 90 days | 81.94 | about 29.48 |
Based on a normal probability distribution, the odds of Amdocs to move above the current price in 90 days from now is about 29.48 (This Amdocs probability density function shows the probability of Amdocs Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Amdocs has a beta of 0.46 suggesting as returns on the market go up, Amdocs average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Amdocs will be expected to be much smaller as well. Additionally Amdocs has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Amdocs Price Density |
| Price |
Predictive Modules for Amdocs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amdocs. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amdocs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Amdocs is not an exception. The market had few large corrections towards the Amdocs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amdocs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amdocs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.05 | |
β | Beta against Dow Jones | 0.46 | |
σ | Overall volatility | 3.30 | |
Ir | Information ratio | -0.05 |
Amdocs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amdocs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amdocs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Amdocs generated a negative expected return over the last 90 days | |
| On 30th of January 2026 Amdocs paid $ 0.527 per share dividend to its current shareholders | |
| Latest headline from news.google.com: 1 Safe-and-Steady Stock to Research Further and 2 That Underwhelm - The Globe and Mail |
Amdocs Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amdocs Stock often depends not only on the future outlook of the current and potential Amdocs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amdocs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 111.7 M | |
| Cash And Short Term Investments | 325 M |
Amdocs Fundamentals Growth
Amdocs Stock prices reflect investors' perceptions of the future prospects and financial health of Amdocs, and Amdocs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amdocs Stock performance.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0804 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 9.25 B | ||||
| Shares Outstanding | 107.95 M | ||||
| Price To Earning | 19.03 X | ||||
| Price To Book | 2.58 X | ||||
| Price To Sales | 1.99 X | ||||
| Revenue | 4.53 B | ||||
| Gross Profit | 1.72 B | ||||
| EBITDA | 927.1 M | ||||
| Net Income | 567.77 M | ||||
| Cash And Equivalents | 817.98 M | ||||
| Cash Per Share | 6.74 X | ||||
| Total Debt | 826.4 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 1.60 X | ||||
| Book Value Per Share | 31.62 X | ||||
| Cash Flow From Operations | 749.1 M | ||||
| Earnings Per Share | 5.05 X | ||||
| Market Capitalization | 9.01 B | ||||
| Total Asset | 6.25 B | ||||
| Retained Earnings | 7.16 B | ||||
| Working Capital | 233.34 M | ||||
| Current Asset | 2.1 B | ||||
| Current Liabilities | 1.37 B | ||||
About Amdocs Performance
Evaluating Amdocs' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Amdocs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amdocs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 27.01 | 18.76 | |
| Return On Tangible Assets | 0.16 | 0.10 | |
| Return On Capital Employed | 0.19 | 0.18 | |
| Return On Assets | 0.08 | 0.06 | |
| Return On Equity | 0.15 | 0.16 |
Things to note about Amdocs performance evaluation
Checking the ongoing alerts about Amdocs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amdocs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amdocs generated a negative expected return over the last 90 days | |
| On 30th of January 2026 Amdocs paid $ 0.527 per share dividend to its current shareholders | |
| Latest headline from news.google.com: 1 Safe-and-Steady Stock to Research Further and 2 That Underwhelm - The Globe and Mail |
- Analyzing Amdocs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amdocs' stock is overvalued or undervalued compared to its peers.
- Examining Amdocs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amdocs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amdocs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amdocs' stock. These opinions can provide insight into Amdocs' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Amdocs Stock Analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.